Guardant Health (GH) Non-Current Deffered Revenue (2017 - 2019)

Guardant Health has reported Non-Current Deffered Revenue for 3 years, with the latest figure at $10.6 million in Q3 2019.

• Quarterly Non-Current Deffered Revenue rose 38.58% year-over-year to $10.6 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $10.6 million (up 38.58% YoY) and the FY2018 annual result came in at $7.8 million, up 19.99% from the prior year.
• Non-Current Deffered Revenue declined to $10.6 million in Q3 2019 per GH's latest filing, from $10.9 million in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $10.9 million in Q2 2019 and troughed at $6.5 million in Q4 2017.
• A 3-year average of $8.7 million and a median of $8.4 million in 2018 frame the typical range for Non-Current Deffered Revenue.
• The sharpest annual moves came in 2018 and 2019: Non-Current Deffered Revenue advanced 19.99% in 2018, then jumped 38.58% in 2019.
• Over 3 years, Non-Current Deffered Revenue stood at $6.5 million in 2017, then rose by 19.99% to $7.8 million in 2018, then jumped by 34.68% to $10.6 million in 2019.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $10.6 million, $10.9 million, and $9.0 million for Q3 2019, Q2 2019, and Q1 2019 respectively.